SSKN - メラ・サイエンス (Strata Skin Sciences Inc.) メラ・サイエンス

 SSKNのチャート


 SSKNの企業情報

symbol SSKN
会社名 Strata Skin Sciences Inc (メラ・サイエンス)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 ストラタ・スキン・サイエンス(Strata Skin Sciences Inc.)(旧名:MELA Sciences Inc.)は、医療機器会社である。同社は、皮膚がん早期検査のソフト駆動技術の設計・開発に従事する。同社は、皮膚病の再発性プログラム、皮膚病プログラムと皮膚病学検査という3つのセグメントにおいて運営する。同社の製品は、乾癬・白斑など様々な皮膚病の治療に使われるXTRACレーサー、VTRACエキシマ燈システムなどがある。また、同社は「MelaFind」という製品の商業化に集中する。「MelaFind」は黒色腫の診断に役立つ非侵襲性ポイント・オブ・ケア(医者のオフィスで)機器であい、多波長の光を発し、疑わしい色素性皮膚病変の画像を取り、データを抽出する手持ち式撮像装置である。そのデータは画像処理分類アルゴリズムを用いて、黒色腫と良性病変のデータベースに合わせて分析される。  メラ・サイエンスは、医療機器メ―カ―。同社製品は、黒色腫の検出を補助する器具「MelaFind」。「MelaFind」システムの構成要素は、光学系とマルチスペクトル照明を採用する手持ち部品、色素性皮膚病変のデ―タベ―ス、病変の特徴情報を抽出し分類する数学的アルゴリズムされている病変分類器などがある。   STRATA Skin Sciences is a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTRAC® excimer laser and VTRAC® lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. The Company's proprietary XTRAC® excimer laser delivers a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases which impact over 35 million patients in the United States alone. The technology is covered by multiple patents, including exclusive rights for patents for the delivery of treatment to vitiligo patients. STRATA's unique business model leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company's partner dermatology clinics. The XTRAC business has used this proven DTC model to grow its domestic dermatology partner network to over 832 clinics, with a worldwide installed base of over 2,000 devices. The Company is able to offer 90% of DTC patients an introduction to physicians prescribing a reimbursable solution, using XTRAC, within a 10-mile radius of their house. The Company is a leader in dermatology in-clinic business generation for its partners. The Company has now introduced its Home by XTRAC™ business leveraging in-house resources including DTC advertising, in-house call center and its insurance reimbursement team to provide an at-home, insurance-reimbursed treatment option for patients with certain skin diseases that do not qualify for in-office treatments.
本社所在地 100 Lakeside Drive Suite 100 Horsham PA 19044 USA
代表者氏名 LuAnn Via LuAnn Via
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 215-619-3200
設立年月日 32843
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 96人
url www.strataskinsciences.com
nasdaq_url https://www.nasdaq.com/symbol/sskn
adr_tso
EBITDA EBITDA(百万ドル) 1.04900
終値(lastsale) 3.2199
時価総額(marketcap) 96413742.6114
時価総額 時価総額(百万ドル) 96.11731
売上高 売上高(百万ドル) 29.47400
企業価値(EV) 企業価値(EV)(百万ドル) 89.04531
当期純利益 当期純利益(百万ドル) 4.86500
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 STRATA Skin Sciences Inc revenues decreased 11% to $14M. Net loss increased 4% to $3.6M. Revenues reflect Dermatology Recurring Procedures segment decrease of 62% to $4.5M Dermatology Procedures Equipment segment decrease of 51% to $2M United States (Country) segment decrease of 61% to $5.2M Foreign segment decrease of 51% to $1.3M.

 SSKNのテクニカル分析


 SSKNのニュース

   STRATA Skin Sciences to Present at Fall Harvest Best Ideas from the Buy-Side on Wednesday, October 6th, 2021  2021/09/29 12:00:00 Intrado Digital Media
HORSHAM, Pa., Sept. 29, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that the Company has been invited to present at the Fall Harvest Best Ideas from the Buy-Side conference. CEO, Robert J. Moccia will present at the conference.
   STRATA Skin Sciences to Participate in Upcoming Investor Conferences  2021/09/02 20:05:00 Intrado Digital Media
HORSHAM, Pa., Sept. 02, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in two upcoming investor conferences.
   Ra Medical To Focus On Peripheral Artery Disease With Pharos Dermatology Divestiture  2021/08/17 09:16:50 Benzinga
Ra Medical Systems Inc (NYSE: RMED ) has sold its Pharos dermatology business to STRATA Skin Sciences Inc (NASDAQ: SSKN ) for $3.7 million in cash. The Pharos excimer laser is an FDA-cleared treatment for psoriasis, vitiligo, atopic dermatitis, and leukoderma. "We believe this transaction is in the best Full story available on Benzinga.com
   STRATA Skin Sciences, Inc. (SSKN) CEO Robert Moccia on Q2 2021 Results - Earnings Call Transcript  2021/08/17 01:44:08 Seeking Alpha
   Ra Medical Systems sells Pharos dermatology business to STRATA Skin Sciences  2021/08/16 20:26:49 Seeking Alpha
   Strata Skin Sciences Consensus Indicates Potential 166.7% Upside  2021/06/23 12:06:15 DirectorsTalk
Strata Skin Sciences found using ticker (SSKN) now have 3 analysts covering the stock. The analyst consensus points to a rating of ''Strong_Buy''. The target price ranges between 5 and 3 calculating the mean target price we have 3.92. Given that the stocks previous close was at 1.47 this is indicating there is a potential upside of 166.7%. The day 50 moving average is 1.51 and the 200 moving average now moves to 1.39. The market cap for the company is $47m. You can visit the company''s website by visiting: /> [stock_market_widget type="chart" symbol="SSKN" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] STRATA Skin Sciences, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States and Asia. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others.
   Here is What Hedge Funds Think About Strata Skin Sciences, Inc. (SSKN)  2021/06/14 20:00:27 Insider Monkey
   STRATA Skin Sciences to Participate in the Oppenheimer MedTech, Tools & Diagnostics Summit  2021/05/18 12:00:00 GlobeNewswire
HORSHAM, Pa., May 18, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in the upcoming Oppenheimer MedTech, Tools & Diagnostics Summit.
   Analysts Offer Insights on Healthcare Companies: Strata Skin Sciences (SSKN), Flexion Therapeutics (FLXN) and MedMen Enterprises (OtherMMNFF)  2021/05/13 11:20:21 Smarter Analyst
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Strata Skin Sciences (SSKN), Flexion Therapeutics The post Analysts Offer Insights on Healthcare Companies: Strata Skin Sciences (SSKN), Flexion Therapeutics (FLXN) and MedMen Enterprises (OtherMMNFF) appeared first on Smarter Analyst .
   Analysts Are Bullish on These Healthcare Stocks: Strata Skin Sciences (SSKN), Acceleron Pharma (XLRN)  2021/05/13 10:15:39 Smarter Analyst
Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Strata Skin Sciences (SSKN), Acceleron The post Analysts Are Bullish on These Healthcare Stocks: Strata Skin Sciences (SSKN), Acceleron Pharma (XLRN) appeared first on Smarter Analyst .
   Here is What Hedge Funds Think About Strata Skin Sciences, Inc. (SSKN)  2021/06/14 20:00:27 Insider Monkey
   STRATA Skin Sciences to Participate in the Oppenheimer MedTech, Tools & Diagnostics Summit  2021/05/18 12:00:00 GlobeNewswire
HORSHAM, Pa., May 18, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in the upcoming Oppenheimer MedTech, Tools & Diagnostics Summit.
   Analysts Offer Insights on Healthcare Companies: Strata Skin Sciences (SSKN), Flexion Therapeutics (FLXN) and MedMen Enterprises (OtherMMNFF)  2021/05/13 11:20:21 Smarter Analyst
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Strata Skin Sciences (SSKN), Flexion Therapeutics The post Analysts Offer Insights on Healthcare Companies: Strata Skin Sciences (SSKN), Flexion Therapeutics (FLXN) and MedMen Enterprises (OtherMMNFF) appeared first on Smarter Analyst .
   Analysts Are Bullish on These Healthcare Stocks: Strata Skin Sciences (SSKN), Acceleron Pharma (XLRN)  2021/05/13 10:15:39 Smarter Analyst
Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Strata Skin Sciences (SSKN), Acceleron The post Analysts Are Bullish on These Healthcare Stocks: Strata Skin Sciences (SSKN), Acceleron Pharma (XLRN) appeared first on Smarter Analyst .
   STRATA Skin Sciences, Inc. (SSKN) CEO Robert Moccia on Q1 2021 Results - Earnings Call Transcript  2021/05/13 01:06:07 Seeking Alpha

 関連キーワード  (先端医療機器_テクノロジ― 米国株 メラ・サイエンス SSKN Strata Skin Sciences Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)